Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom.

ABSTRACT:

Background

The legal status of kratom in the United States is complex and varies by state. The U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration have repeatedly subjected kratom to regulatory review. However, there hasn't been a systematic review of the public's perception of kratom. The present study analyzed open-ended responses from the public to an FDA solicitation for information regarding kratom with the goal of providing a comprehensive assessment of motives for kratom use.

Methods

To guide decisions regarding kratom regulation, the FDA solicited comments regarding kratom abuse potential, medical usefulness, and impact of scheduling changes from July through August 2021 and posted them to the Federal Register website. We analyzed com

SUBMITTER: Tobacyk J 

PROVIDER: S-EPMC10243221 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature